Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 23Observational 1

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 3Gynecologic 1

Conditions

Cervical Cancer Metastatic 1

Interventions

Surveys and Questionnaires 58Blood Specimen Collection 31Surgical Procedures, Operative 13Interviews as Topic 13Immunohistochemistry 13Data Collection 13niraparib 12Hyperthermic Intraperitoneal Chemotherapy 11Observation 10Drug Therapy 10Cytoreduction Surgical Procedures 10Magnetic Resonance Spectroscopy 9Radiotherapy 8Polymerase Chain Reaction 8Papanicolaou Test 8Colposcopy 8Cisplatin 8Biopsy 8Amplified Fragment Length Polymorphism Analysis 8olaparib 7Carboplatin 7Ultrasonography 6Sentinel Lymph Node Biopsy 6Psychiatric Rehabilitation 6Paclitaxel 6Microarray Analysis 6Laparoscopy 6Hysterectomy 6DNA Methylation 6liposomal doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × camrelizumab × Gynecologic × Clear all
NCT07266350 2025-12-05

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Chongqing University Cancer Hospital

Not yet recruiting
1,300 enrolled
Gynecologic

Cervical Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡